RhumbLine Advisers
TTPH

RhumbLine Advisers’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

RhumbLine Advisers’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,635
Closed -$97K – 3043
2019
Q1 		$97K Sell
3,635
-14
-0.4% -$356 ﹤0.01% 2863
2018
Q4 		$82K Buy
3,649
+1,055
+41% +$41.3K ﹤0.01% 2902
2018
Q3 		$143K Buy
2,594
+15
+0.6% +$958 ﹤0.01% 2811
2018
Q2 		$184K Buy
2,579
+181
+8% +$12.8K ﹤0.01% 2755
2018
Q1 		$147K Sell
2,398
-311
-11% -$27.3K ﹤0.01% 2675
2017
Q4 		$341K Sell
2,709
-171
-6% -$21.9K ﹤0.01% 2399
2017
Q3 		$394K Buy
2,880
+298
+12% +$39.9K ﹤0.01% 2437
2017
Q2 		$368K Buy
2,582
+139
+6% +$21.5K ﹤0.01% 2458
2017
Q1 		$449K Buy
2,443
+317
+15% +$35.5K ﹤0.01% 2296
2016
Q4 		$171K Sell
2,126
-721
-25% -$57K ﹤0.01% 2708
2016
Q3 		$218K Sell
2,847
-25
-0.9% -$2K ﹤0.01% 2632
2016
Q2 		$247K Buy
2,872
+959
+50% +$87.9K ﹤0.01% 2637
2016
Q1 		$177K Buy
1,913
+34
+2% +$3.4K ﹤0.01% 2771
2015
Q4 		$377K Buy
1,879
+183
+11% +$36.5K ﹤0.01% 2434
2015
Q3 		$253K Buy
1,696
+51
+3% +$37.4K ﹤0.01% 2654
2015
Q2 		$1.56M Buy
1,645
+402
+32% +$329K 0.01% 1582
2015
Q1 		$911K Buy
1,243
+239
+24% +$180K ﹤0.01% 1921
2014
Q4 		$797K Buy
1,004
+147
+17% +$79.1K ﹤0.01% 1965
2014
Q3 		$342K Hold
857
– – ﹤0.01% 2453
2014
Q2 		$231K Buy
857
+334
+64% +$71.7K ﹤0.01% 2749
2014
Q1 		$114K Buy
+523
New +$146K ﹤0.01% 2907
2013
Q3 		– Sell
-501
Closed -$70K – 2994
2013
Q2 		$70K Buy
+501
New +$79.3K ﹤0.01% 3281

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RhumbLine Advisers's TTPH Position: Q2 2019 in Review

RhumbLine Advisers sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 3,635 shares — an estimated $97K sold.

RhumbLine Advisers first reported a position in TTPH in Q2 2013 and held it in 22 quarters. The position peaked at $1.56M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • RhumbLine Advisers reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 3,635 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $97K.
  • RhumbLine Advisers first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 22 quarters.
  • RhumbLine Advisers's Tetraphase Pharmaceuticals, Inc. position peaked at $1.56M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.